онкология

1857 проекта

H2020Индивидуална стипендия2018–2019Италия

THAT IS HUNT · Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cell receptors

H2020Индивидуална стипендия2018–2020Италия

IC_IL_EC_2017 · Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers

H2020Индивидуална стипендия2018–2020Франция

RoNDBioCan · NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway

2 партньори

H2020Индивидуална стипендия2018–2020Испания

CINK · Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers

H2020Индивидуална стипендия2018–2020Испания

DUALITY · An Integrated Computational and Experimental Approach to Rapid Synthesis of Highly Selective Dual-Targeted HDAC/CK2, MMP2/CK2 Inhibitors

H2020Индивидуална стипендия2018–2020Обединеното кралство

JTIM · Biodegradable Water-Soluble Cylindrical Block Copolymer Micelles and their Applications in Nanomedicine

H2020Индивидуална стипендия2018–2020Португалия

DevoSignGammaDelta · Tracking γδ T cell development and TCRγδ proximal signalling

H2020Индивидуална стипендия2018–2019Дания

DNAmethAML · Investigation of aberrant DNA methylation in malignant haematopoiesis

H2020Индивидуална стипендия2018–2020Португалия

TRIBBLES · Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma

H2020Индивидуална стипендия2018–2020Испания

PhoRAu · Photochemistry and radiolabelling of gold(III) anticancer prodrugs

H2020Индивидуална стипендия2018–2019Швейцария

DREMATURE · DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers

H2020Индивидуална стипендия2018–2020Швеция

DrugSearchTool · Innovative FRET-based toolkit for screening of drugs to fight miRNA-related diseases and its use in the development of cancer treatment with miRNA-96 as a therapeutic target

H2020Индивидуална стипендия2018–2020Обединеното кралство

MATESI · Multi-modal Approaches for Treatment and Evaluation of Swallowing Insufficiencies

H2020Индивидуална стипендия2018–2020Ирландия

TSPO METALLODRUGS · Novel, highly effective and selective anticancer metallodrugs

H2020Индивидуална стипендия2018–2020Обединеното кралство

BRAINHIB · Integrated drug discovery approach to generate brain-penetrant inhibitors of glioblastoma cell proliferation

H2020Обмен на изследователи2017–2022Италия

Nano-OligoMed · Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications

8 партньори · 6 държави

H2020Индивидуална стипендия2017–2019Швеция

GOTBONE · Novel mechanisms of site-specific regulation of bone strength for the prevention of osteoporotic fractures: a translational project

H2020Индивидуална стипендия2017–2019Обединеното кралство

ORI NUMBER · Unravelling the effect of origin number on the success of genome replication

H2020Докторантска мрежа2017–2021Испания

VIRO-FLOW · Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors

2 партньори · 2 държави

H2020Индивидуална стипендия2017–2019Франция

ESEMT · DETERMINING THE FUNCTIONAL CONSEQUENCES OF TRANSCRIPTIONAL ENHANCER ACTIVATION ON ALTERNATIVE SPLICING DURING EMT

H2020Докторантска мрежа2017–2022Нидерландия

PREDICT · A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology

18 партньори · 6 държави

H2020Докторантска мрежа2017–2021Ирландия

GLIOTRAIN · Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics

23 партньори · 8 държави

H2020Докторантска мрежа2017–2022Нидерландия

DRIVE · Driving next generation autophagy researchers towards translation

35 партньори · 11 държави

H2020Индивидуална стипендия2017–2019Швейцария

ADVaNCE · ADVerse outcome Network for non-mutagenic CarcinogEns